Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
This settlement is closed!
Please see what other class action settlements you might qualify to claim cash from in our Open Settlements directory!
Follow us on Twitter and Facebook for the latest Class Action Settlement News!
We’re sorry! This settlement is CLOSED!
Please join the Top Class Actions Newsletter
list so you don’t miss out next time and head
over to the OPEN LAWSUIT SETTLEMENTS section
to see what’s available!
Â
Â
Flonase Direct Purchaser Class Action Lawsuit Settlement
Â
Award (how much your claim may be worth): You can receive a cash refund from the Flonase direct purchaser class action settlement.
Click here to skip the legal notice and go straight to the Top Class Actions article on this class action lawsuit settlement.
Â
No Notice
Class Action Lawsuit Settlement Case(s):In re Flonase Antitrust Litigation, Case No. 8-cv-3149, in the Eastern District of Pennsylvania.
Company(ies): SMITHKLINE BEECHAM CORP. d/b/a GLAXOSMITHKLINE
Address to submit a claim form (REQUIRED):
Â
Phone Number to call for assistance: (800) 760-6903
Details: The Flonase direct settlement will resolve a class action lawsuit titled In re: Flonase Indirect Antitrust Litigation that claims GSK violated state laws by delaying the availability of generic versions of the nasal allergy spray. Plaintiffs alleged that GSK attempted to monopolize the market by filing sham citizen petitions with the U.S. Food and Drug Administration to delay the entry of cheaper, generic versions of Flonase into the market. As a result, direct purchasers of Flonase were injured by paying more for the nasal spray than they would have paid otherwise had less expensive, generic versions of Flonase been available.
GSK denies these claims and any wrongdoing, but has agreed to a class action lawsuit settlement to resolve the allegations.
Class Members of the Flonase direct settlement include all persons or entities in the U.S. who purchased Flonase nasal spray directly from GSK or any of its predecessors or affiliates at any time from May 19, 2004 until March 6, 2006.
Â
NOTE: If you are a consumer who purchased Flonase indirectly from GSK, a separate class action settlement applies to you. Go to the Flonase Indirect Purchaser Class Action Lawsuit Settlement for details.
Class Members of the Flonase Direct Purchaser class action settlement that submit a valid Claim Form by the deadline of July 19, 2013 will receive a cash refund from the class action settlement. The amount of this payment will be based on how much money you paid during the Class Period and many Class Members file valid claims.
More information on your rights in the Flonase Class Action Lawsuit Settlement can be found at www.FlonaseDirectSettlement.com.
Â
Purchased Between: May 19, 2004 and March 6, 2006
Claims must be postmarked by: 7/19/13
Â
Settlement Administrator(s): Rust Consulting
Class Counsel:
Â
Joseph H. Meltzer
KESSLER TOPAZ MELTZER & CHECK, LLP
Â
Thomas M. Sobol
HAGENS BERMAN SOBOL SHAPIRO LLP
Defense Counsel:
Stephen Kastenberg
BALLARD SPAHR LLP
LEGAL INFORMATION IS NOT LEGAL ADVICE
This site provides information about the law and class action lawsuit settlements designed to help users safely cope with their own legal needs. Legal information is NOT the same as legal advice – the application of law to an individual’s specific circumstances. Although we go to great lengths to make sure our information is accurate and useful, we recommend you consult a lawyer if you want professional assurance that our information, and your interpretation of it, is appropriate to your particular situation. You should consider all postings or writings at TopClassActions.com by staff or others as personal opinion only and NOT the advice of a lawyer. Top Class Actions Legal Statement
©2008 – 2013 Top Class Actions® LLC
Various Trademarks held by their respective owners.
Â